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Although Nα-terminal acetylation (Nt-acetylation) is a per-
vasive protein modification in eukaryotes, its general func-
tions in a majority of proteins are poorly understood. In 
2010, it was discovered that Nt-acetylation creates a spe-
cific protein degradation signal that is targeted by a new 
class of the N-end rule proteolytic system, called the Ac/N-
end rule pathway. Here, we review recent advances in our 
understanding of the mechanism and biological functions 
of the Ac/N-end rule pathway, and its crosstalk with the 
Arg/N-end rule pathway (the classical N-end rule pathway).1 
 
 
INTRODUCTION  
 
Conditional and constitutive proteolysis are essential life pro-
cesses. Living cells exploit metabolic turnover to adjust intracel-
lular protein levels, restrict unwanted or aberrant protein accu-
mulation, and supply protein and peptide fragments or free 
amino acids for physiological needs (Varshavsky, 2011; Zattas 
and Hochstrasser, 2015). Malfunctions in regulated proteolysis 
lead to the accumulation of misfolded or abnormal proteins, 
causing many fatal diseases, including cancers, immunological 
or neurobiological disorders, as well as aging (Ciechanover and 
Kwon, 2015; Varshavsky, 2011). Detailed knowledge of intracel-
lular proteolytic machineries and their modes of action will 
therefore provide new insight into drug interventions for the 
treatment of devastating maladies or general health mainte-
nance. 
The ubiquitin-proteasome system (UPS) is involved in the 
majority of regulated proteolysis within a cell. The first well-
defined protein degradation signals (degrons) in the UPS were 
N-degrons, which comprise destabilizing Nt-residues. Their 
detailed examination has revealed the N-end rule, which ena-
bles an Nt-residue or its modification to regulate the in vivo half-
life of a protein (Varshavsky, 2011). The original (classical) N-
end rule pathway (now called the Arg/N-end rule pathway) tar-
gets unmodified destabilizing Nt-residues for degradation 
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(Bachmair et al., 1986). In contrast, a new branch of the N-end 
rule pathway (called the Ac/N-end rule pathway) recognizes the 
Nt-acetyl group of cellular proteins for proteolysis (Hwang et al., 
2010b). Recent studies on the Ac/N-end rule pathway have 
revealed a variety of cellular functions, including protein quality 
and subunit stoichiometry control (Hwang et al., 2010b; Kim 
and Hwang, 2014; Kim et al., 2014; Shemorry et al., 2013), 
blood pressure regulation via G-protein signaling (Park et al., 
2015), and immune responses to pathogens in plants (Xu et al., 
2015). Here, we review current knowledge related to the mech-
anism and biological functions of the Ac/N-end rule pathway. 
 
NT-ACETYLATION, MACHINERY, AND FUNCTIONS 
 
Nascent cellular proteins harbor Nt-methionine (Nt-Met), 
which is co-translationally removed by ribosome-bound Met-
aminopeptidases (MetAPs) if small residues (Ala, Gly, Ser, 
Cys, Thr, Pro, or Val) are positioned at the penultimate site. 
Nt-Met removal is evolutionarily conserved and occurs in 
approximately two-thirds of cellular proteins (Giglione et al., 
2015). In eukaryotes, both retained Nt-Met and newly ex-
posed Nt-residues (immediately after Nt-Met removal or 
their proteolytic cleavage) are very frequently Nα-terminally 
acetylated (Nt-acetylated); Nt-acetylation occurs in 80-90% 
and 50-70% of cytosolic human and yeast proteins, respec-
tively (Van Damme et al., 2012). Unlike the reversible Nε-
acetylation/deacetylation, Nt-acetylation appears to be irre-
versible because no Nt-deacetylases have been identified to 
date (Starheim et al., 2012). Additionally, Nt-acetylation 
takes place both cotranslationally and posttranslationally in 
vivo (Gautschi et al., 2003). 
Nt-acetylases catalyze the covalent attachment of an acetyl 
moiety from acetyl-CoA to the free α-amino group of a protein, 
which alters the steric or chemical properties of the N-
terminus of a protein by neutralizing its positive charge and 
making the Nt-residue larger and more hydrophobic (Aksnes 
et al., 2015b). Nt-acetylases belong to the GCN5-related N-
acetyltransferase (GCNT) family (Polevoda et al., 1999) and 
are classified as NatA, NatB, NatC, NatD, NatE, and NatF 
based on substrate specificity and subunit compositions. The 
substrate specificity of each Nt-acetylase is mostly based on 
the first two protein residues. Of the 6 Nt-acetylases (NatA to 
F), NatA, NatB, and NatC primarily act on protein N-termini 
(Aksnes et al., 2015b) (Fig. 1). 
NatA consists of a catalytic subunit Naa10 (Ard1) and an 
auxiliary subunit Naa15 (Nat1) (Mullen et al., 1989; Park and 
Szostak, 1992), and acetylates Ser, Ala, Cys, Gly, Thr, and Val  
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N-termini (Aksnes et al., 2015b) (Fig. 1). NatA functions in cell 
proliferation, gene silencing, stress resistance, mating process, 
ribosome biogenesis, apoptosis, protein folding and disaggre-
gation, photosynthesis, development, and stress responses 
(Aksnes et al., 2015b; Dorfel and Lyon, 2015). Loss of NatA 
causes a wide range of phenotypes depending on organisms, 
from slight growth defects to lethality (Aksnes et al., 2015b; 
Dorfel and Lyon, 2015). In humans, dysregulation of NatA re-
sults in various cancer types and neuronal diseases (Kalvik and 
Arnesen, 2013). In particular, missense or splicing mutations of 
Naa10, a catalytic subunit of NatA, cause X-linked human ge-
netic disorders, including Ogden Syndrome (Rope et al., 2011) 
and Lenz microphthalmia syndrome (Esmailpour et al., 2014). 
NatB contains a catalytic subunit, Naa20, and an auxiliary 
subunit, Naa25, and specifically targets N-terminal Met with Asn, 
Asp, Gln, or Glu at the second position (Fig. 1). NatB plays 
roles in cell growth in response to various stressors, mitochon-
drial inheritance, actin cable formation, cell wall maintenance, 
flowering regulation, plant development, etc. (Aksnes et al., 
2015b; Ferrandez-Ayela et al., 2013; Lee et al., 2014). 
NatC has a catalytic subunit, Naa30, and two accessory 
subunits, Naa35/Naa38, and primarily acetylates Nt-Met with 
bulky hydrophobic residues at position 2 (Fig. 1). It affects cell 
growth, protein targeting, viral particle maintenance, stress 
responses, chloroplast development, etc. (Aksnes et al., 2015b; 
Pesaresi et al., 2003). 
NatD, NatE, and NatF include only catalytic subunits Naa40, 
Naa50, and Naa60, respectively. NatD acetylates solely the N-
terminus of histone H2A or H4 and partially regulates histone 
modification and ribosomal DNA silencing (Polevoda et al., 
2009). NatE and NatF display slightly overlapping substrate 
specificities with NatC. NatE is involved in chromosome segre-
gation and microtubule growth. Interestingly, membrane-
localized NatF is only found in multicellular organisms and 
mainly acetylates cytosolic-faced N-termini of transmembrane 
proteins, thus maintaining Golgi structural integrity (Aksnes et 
al., 2015b; 2015c; Van Damme et al., 2011). 
The function of Nt-acetylation on a vast number of cellular 
proteins has remained a conundrum since its discovery (Narita, 
1958). However, studies on individual proteins have revealed 
that Nt-acetylation contributes to protein stability, degradation, 
interactions, targeting, activity, etc. (Behnia et al., 2004; Forte et 
al., 2011; Hwang et al., 2010b; Jornvall, 1975; Scott et al., 2011; 
Setty et al., 2004). Schulman and colleagues have shown that 
Nt-acetylation of the E2 enzyme Ubc12 increases its binding 
affinity to the E3 ligase Dcn1 by approximately ~100-fold, 
thereby promoting E3 ligase activity (Scott et al., 2011). In addi-
tion, Nt-acetylation affects global protein folding, chaperone 
expression, prion stability, and disaggregation of neurodegen-
erative proteins, such as β-amyloid, huntingtin, or α-synuclein 
(Arnesen et al., 2010; Holmes et al., 2014; Pezza et al., 2009). 
Nt-acetylation also precludes the targeting of cytosolic proteins 
to the endoplasmic reticulum (ER) (Forte et al., 2011) and 
transit polypeptide import into plastids (Bischof et al., 2011). 
Nt-acetylation has been largely regarded as a metabolic sta-
bilizer that protects proteins or peptides from destruction 
(Jornvall, 1975). For example, Nt-acetylated globins and lyso-
zymes are more stable than their unacetylated counterparts 
(Hershko et al., 1984). Nt-acetylation also blocks the Nt-
ubiquitylation-mediated degradation of several cellular proteins, 
in which a linearly attached Nt-Ub moiety serves as a specific 
degron (Ciechanover and Ben-Saadon, 2004). Furthermore, 
Nt-acetylation stabilizes Arg/N-end rule substrates by directly 
inhibiting N-degron recognition by the Arg/N-end rule pathway 
(Varshavsky, 2011) (see below). However, Nt-acetylation also 
creates a specific degron that is targeted by the Ac/N-end rule 
pathway (Hwang et al., 2010a; Varshavsky, 2011). 
 
N-DEGRONS, THE N-END RULE, AND THE ARG/N-END  
RULE PATHWAY 
 
Ubiquitin (Ub) is a small 76-amino-acid protein that is highly 
conserved across all eukaryotes. Ubiquitylation links the car-
boxyl terminus of Gly in Ub to the Nε-group of Lys or, relatively 
rarely, to the Nα-amino group of Met in cellular proteins. The 
covalent linkage of Ub to target substrates requires consecutive 
reactions of Ub-activating enzymes (E1s), Ub-conjugating en-
zymes (E2s), and Ub ligases (E3s). The ubiquitylation reaction 
repeats several times to generate a polyubiquitylated sub-
strate that is selectively eliminated by the 26S proteasome. In 
the UPS, E3 ligase directly contacts target substrates for 
polyubiquitylation and subsequent proteasomal degradation 
(Varshavsky, 2011; Zattas and Hochstrasser, 2015). One fun-
damental question related to the UPS is exactly what structural 
or sequence features within a target protein trigger its Ub-
mediated destruction by the 26S proteasome; are there any 
specific degrons (Kim and Hwang, 2014; Ravid and 
Hochstrasser, 2008)? 
Varshavsky and colleagues first defined the primary degrons 
in the UPS (called N-degrons) based on the unexpected obser-
vation that the half-lives of engineered β-galactosidases with 
varied Nt-residues are determined by an exposed Nt-residue in 
Saccharomyces cerevisiae (Bachmair et al., 1986). According 
to the stability of the resulting β-galactosidases, they classified 
Nt-amino acids as either stabilizing or destabilizing residues 
(Bachmair et al., 1986). N-degrons include primary destabilizing  
Fig. 1. Substrate specificity and subunit compositions of Nt-
acetylases. Among 6 Nt-acetylases (NatA-F), NatA, NatB, and 
NatC mainly Nt-acetylate cellular proteins. NatA consists of a cata-
lytic subunit, Naa10, and an auxiliary subunit, Naa15, and acety-
lates Ser (S), Ala (A), Cys (C), Gly (G), Thr (T), or Val (V) N-termini 
of its substrates after Nt-Met removal by methionine aminopepti-
dases (MetAPs). NatB consists of a catalytic subunit, Naa20, and 
an auxiliary subunit, Naa25, and Nt-acetylates Met-Asn (MN), Met-
Asp (MD), Met-Gln (MQ), or Met-Glu (ME) on cellular proteins. 
NatC contains a catalytic subunit, Naa30, and auxiliary subunits, 
Naa35 and Naa38, and Nt-acetylates Met-Ile (MI), Met-Phe (MF), 
Met-Trp (MW), Met-Leu (ML), or Met-Tyr (MY) on its substrates. 
The Ac/N-End Rule Pathway 
Kang-Eun Lee et al. 
 
 
 
http://molcells.org  Mol. Cells  171 
 
 
Nt-residues, internal Lys residue(s) for ubiquitylation, and flexi-
ble region(s) for the exposure of substrate Nt-residues. Exten-
sive examination of N-degrons has revealed the N-end rule and 
the related proteolytic system, called the N-end rule pathway 
(Tasaki et al., 2012; Varshavsky, 2011).  
The N-end rule pathway is generally grouped into the Arg/N-
end rule pathway and the Ac/N-end rule pathway in eukaryotes 
(Fig. 2). The Arg/N-end rule pathway targets specific unmodi-
fied Nt-residues for polyubiquitin-mediated proteolysis by the 
26S proteasome (Varshavsky, 2011) or, to a lesser extent, by 
autophagy (Cha-Molstad et al., 2015) (Fig. 2A). In eukaryotes, 
the Arg/N-end rule pathway employs specific UBR-type E3 
ligases as N-recognins, which are recognition components of 
the N-end rule pathway. The UBR-type E3s bind directly to 
unmodified basic (Arg, Lys, His) and large hydrophobic (Leu, 
Phe, Tyr, Trp, Ile) destabilizing Nt-residues. Nt-Asn and Gln can 
act as destabilizing residues through their deamination via Nt-
amidases, resulting in Asp or Glu, and subsequent Nt-
arginylation via Arg-tRNA-protein transferases (ATEs) (Kwon et 
al., 1999; Varshavsky, 2011). Nt-Cys also becomes destabiliz-
ing through its oxidation by NO, oxygen, or cysteine oxidases, 
and entails Nt-arginylation by ATEs. Subsequently, Nt-
arginylated proteins are directly recognized by UBR-type N-
recognins for polyubiquitin-mediated degradation by the 26S 
proteasome (Gibbs, 2015; Tasaki et al., 2012; Varshavsky, 
2011). In addition to primary destabilizing Nt-residues, the 
Arg/N-end rule pathway directly recognizes, for proteolysis, Nt-
Met of cellular proteins with a hydrophobic residue at the 2nd 
position, termed MФ-degrons (Kim et al., 2014) (Fig. 2A).  
The functions of the Arg/N-end rule pathway include sensing 
small molecules (e.g., heme, di/tripeptides, and oxygen), elimi-
nating abnormal proteins, regulating genome stability, apoptosis, 
DNA repair, G-protein signaling, autophagy, fungal pathogene-
sis, plant hormone responses, leaf senescence, cardiac signal-
ing, and the viral life cycle (Cha-Molstad et al., 2015; Dougan et 
al., 2012; Gibbs et al., 2014; Hwang et al., 2010a; Sriram et al., 
2011; Tasaki et al., 2012; Varshavsky, 2011). The Arg/N-end 
rule pathway also mediates the degradation of breast cancer-
related tumor suppressor 1 (BRCA1) (Xu et al., 2012) and the 
Parkinson’s disease-associated protein PTEN-induced putative 
kinase 1 (PINK1) (Yamano and Youle, 2013). Interestingly, loss 
of human UBR1, an E3 ligase of the Arg/N-end rule pathway, 
causes Johanson-Blizzard Syndrome, which is characterized 
by physical malformations and pancreatic exocrine insufficiency 
(Hwang et al., 2011; Zenker et al., 2005). 
 
THE NT-ACETYLATION-TARGETED N-END RULE  
PATHWAY (THE AC/N-END RULE PATHWAY) 
 
The Arg/N-end rule pathway classifies Met, Ser, Thr, Val, Cys, 
Ala, and Pro as stabilizing Nt-residues (Varshavsky, 2011). 
However, Nt-Cys is readily oxidized in mammalian and plant 
cells, and subsequently arginylated by ATEs following its target-
ing to UBR-type N-recognins (Gibbs et al., 2011; Hu et al., 
2005; Lee et al., 2005; Weits et al., 2014). Interestingly, report-
ers with Nt-Cys are apparently long-lived in S. cerevisiae, which 
does not retain typical NO synthases (Hu et al., 2005), but pro-
duces significant amounts of NO or reactive oxygen species 
(Bhattacharjee et al., 2009). Thus, reporters with Nt-Cys were 
assumed to be destabilized only if the Nt-Cys could be oxidized, 
which depends on downstream sequence contexts. Indeed, Nt-
Cys-reporters bearing non-basic residues at position 2 become 
destabilized. Additionally, otherwise identical reporters with Met, 
Ser, Thr, Ala, or Val N-termini are short-lived, in contrast to long-
lived reporters with Nt-Gly or Pro (Hwang et al., 2010b) (Fig. 
2B). The first two Nt-residue-dependence of short-lived report-
ers implicates likely correlation with the substrate specificity of S. 
cerevisiae Nt-acetylases that act on Met, Ala, Val, Ser, Thr, or 
Cys N-termini, but very rarely or never on Nt-Gly or Pro, and Nt-
residues with basic residues at the penultimate site (Aksnes et 
al., 2015b). More interestingly, short-lived reporters with non-
basic residues at position 2 do not involve Ubr1, the sole N-
recognin of the Arg/N-end rule pathway in S. cerevisiae. Instead, 
the reporters are dramatically stabilized in the absence of an 
ER-transmembrane Doa10 E3 ligase, which mediates the deg-
radation of both cytosolic and nuclear or ER proteins in concert 
with Ubc6/Ubc7 E2s (Hwang et al., 2010b; Swanson et al., 
2001) (Fig. 2B). Strikingly, Doa10 preferentially interacts with 
Fig. 2. Two branches of the N-end 
rule pathways in eukaryotes. (A) 
The Arg/N-end rule pathway, which 
targets unmodified Arg, His, Lys, 
Leu, Ile, Phe, Trp, Tyr, and Met-Ф 
(hydrophobic) Nt-residues. Nt-Gln 
and Asn are destabilizing after Nt-
deamidation and subsequent argi-
nylation. Nt-Cys also becomes 
destabilizing through preliminary 
oxidation and subsequent Nt-
arginylation. (B) The Ac/N-end rule 
pathway, which targets Nt-
acetylated residues of cellular pro-
teins for degradation. Doa10 and 
Not4 are yeast Ac/N-recognins and 
Teb4 is a mammalian Ac/N-
recognin. In addition to the NatA, 
NatB, and NatC substrates, other 
Nt-acetylated proteins are potential-
ly targeted by the Ac/N-end rule 
pathway for degradation. 
A 
 
 
 
 
 
B 
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acetylated Nt-Met, Ala, Ser, Cys, Thr, and Val, rather than 
their non-acetylated counterparts. Furthermore, Doa10 is 
required for the degradation of not only artificial model sub-
strates, but also some Nt-acetylated native proteins, including 
MATα2 (a mating type regulator), Tbf1 (a telomerase regula-
tor), Slk19 (a chromosome segregation regulator), His3 (a 
histidine biosynthetic enzyme), Hsp104 (a chaperone), Ubp6 
(a deubiquitylating enzyme), Aro8 (an aromatic aminotrans-
ferase), and Ymr090w (an unknown protein) (Hwang et al., 
2010b). 
Khemlinskii and Knop showed that the degradation of a CL-
mCherry-sfGFP fluorescent protein timer with Nt-Cys-Leu, a 
plausible Ac/N-degron, involves Doa10 E3 ligase and its cog-
nate E2s Ubc6/Ubc7 (Khmelinskii and Knop, 2014). Fields and 
colleagues also demonstrated that chimeric fusions between 
Deg1 (1-67 residues of Matα2) and Leu2 are longer-lived when 
Asn at position 2 is replaced by a basic Lys or Arg (Kim et al., 
2013), which suppresses Nt-acetylation in yeast (Arnesen et al., 
2009). Additionally, Deg1-Leu2 becomes stabilized in an 
naa20Δ mutant that lacks a catalytic subunit of cognate NatB 
Nt-acetylase (Kim et al., 2013), similar to another Deg1-Ura3 
reporter (Hwang et al., 2010a). However, Nt-acetylation slightly 
perturbs the proteolysis of different versions of Deg1-fusion and 
endogenous MATα2 (Zattas et al., 2013). 
 
COMPLEMENTARITY BETWEEN THE ARG/N-END  
RULE AND THE AC/N-END RULE PATHWAYS 
 
Features of Nt-acetylation, e.g., its prevalence, co-
translationality, and apparent irreversibility, indicate that most 
proteins should retain acetylated N-degrons (Ac/N-degrons) 
from their emergence from ribosomes to their destruction 
(Mogk and Bukau, 2010; Varshavsky, 2011). Nonetheless, 
many cellular proteins bear both acetylated and unacetylated 
Nt-residues owing to partial Nt-acetylation. Moreover, some 
cellular proteins are rarely or never Nt-acetylated (Aksnes et al., 
2015b). The built-in property of Ac/N-degrons suggests that 
unacetylated Nt-residues also act as imprinted intrinsic degrons. 
Hence, we presumed that unacetylated stabilizing Nt-residues 
of the Arg/N-end rule pathway might be destabilizing depending 
upon their downstream sequence contexts, especially the 2nd 
residues. To test this possibility, we focused on Nt-Met because 
it is present almost every nascent polypeptide. We found that 
Nt-Met acts as specific protein degrons if it is followed by hy-
drophobic residues (Ф) (Leu, Phe, Ile, Trp, Tyr, Gly, or Ala), and 
these are termed Met-Ф degrons (Kim et al., 2014). Interesting-
ly, yeast Ubr1 and mouse UBR1 and UBR2 E3 ligases of the 
Arg/N-end rule pathway bind specifically to Met-Ф/N-degrons. 
We also showed that the Arg/N-end rule pathway eliminates, 
through Met-Ф/N-degrons, quasi-randomly selected natural 
Met-Ф protein Msn4 (a transcription activator), Sry1 (a 3-
hydroxyaspartate dehydratase), ArI3 (a Golgi-bound GTPase), 
and Pre5 (a proteasome subunit) as well as misfolded Met-Ф 
proteins (Kim et al., 2014). The finding of Met-Ф/N-degrons 
enormously increases the number of Arg/N-end rule substrates 
because more than 15% of DNA-encoded proteins have Nt-
Met-Ф sequences in both yeast and humans. Furthermore, 
detailed analyses of Met-Ф degrons have unraveled the com-
plementary crosstalk between the Ac/N-end rule and the Arg/N-
end rule pathways. For example, when Met-Ф proteins protrude 
from ribosomes, the Arg/N-end rule pathway immediately at-
tacks them for degradation. Otherwise, if Nt-acetylated, the 
Ac/N-end rule pathway is activated and eliminates Met-Ф pro-
teins by recognizing their Nt-acetyl moiety. Consequently, the 
complementary collaboration between the Arg/N-end rule and 
Ac/N-end rule pathways makes it possible to efficiently elimi-
nate Met-Ф proteins irrespective of their Nt-acetylation states 
for physiological needs (Kim and Hwang, 2014; Kim et al., 
2014). Furthermore, Nt-acetylation not only precludes the tar-
geting of Met-Ф proteins by the Arg/N-end rule pathway, but 
also converts Met-Ф/N-degrons into AcMet-Ф/N-degrons, mak-
ing them susceptible to the Ac/N-end rule pathway (Kim and 
Hwang, 2014; Kim et al., 2014). 
A combined analysis of bioinformatics and proteomic data 
has revealed that substantial fractions of proteins (~10%) are 
potentially destroyed by retained Nt-Met (Meinnel et al., 2005). 
In particular, the transient retention of Nt-Met destabilizes chlo-
roplast D2 variants (Giglione et al., 2003), β-glucuronidase in 
plants (Sawant et al., 2001), and a GST variant in S. cerevisiae 
(Chen et al., 2002). Furthermore, Ubr1 may mediate the degra-
dation of a previously identified Met-Ф-type extension of Ura3 
(with Nt-MLDDKCRVTP) via its Nt-Met-Leu sequence (Ghislain 
et al., 1996). In contrast, treatment with the MetAP2 inhibitor 
TNP-470 dramatically stabilizes a Rab37 GTPase (with a Met-
Thr Nt sequence) in murine pulmonary endothelial cells, 
suggesting that the retained Nt-Met of Rab37 also prevents 
its NatA-mediated Nt-acetylation and subsequent degrada-
tion by the Ac/N-end rule pathway (Sundberg et al., 2011). 
Together, the identification of Nt-Met as an N-degron indi-
cates that virtually all 20 amino acids may serve as potential 
destabilizing Nt-residues according to their downstream 
sequence contexts and Nt-acetylation status. For example, 
fructose-1,6-bisphosphatase, a key regulatory enzyme of 
gluconeogenesis, is targeted by the GID (glucose-induced 
degradation-deficient) E3 ligase complex in S. cerevisiae. 
Interestingly, substitutions of the Nt-Pro of fructose-1,6-
bisphosphatase with other residues abrogate its degradation, 
suggesting the GID E3 ligase recognizes the Nt-Pro of the 
metabolic enzyme (Hammerle et al., 1998; Menssen et al., 
2012). Additionally, the Drosophila apoptosis inhibitor DIAP1 
and DIAP2 E3 ligases directly contact Nt-Ala of processed 
caspases for proteolysis as plausible specific Ala/N-degron 
and Ala/N-recognins (Ditzel et al., 2003). Furthermore, the 
replacement of the penultimate site (Pro-2) in thymidylate 
synthase with certain amino acids profoundly influences its 
half-life through Ub-independent proteasomal degradation 
(Pena et al., 2009), similar to bacteria that contain the Ub-
lacking prokaryotic N-end rule pathway (Dougan et al., 
2012). It is unclear which components directly recognize the 
Nt-Pro of thymidylate synthase for Ub-independent proteol-
ysis. 
 
CONTROL OF SUBUNIT STOICHIOMETRY IN  
COMPLEXES BY THE AC/N-END RULE PATHWAY 
 
Although most proteins obtain Ac/N-degrons during or immedi-
ately following their synthesis, the lack of individual Nt-
acetylases does not significantly affect global protein expres-
sion levels, suggesting little correlation between Nt-acetylation 
and protein stability (Garrels et al., 1997; Helbig et al., 2010). 
Ac/N-degrons were, therefore, proposed to be conditionally 
active depending on the accessibility of Ac/N-recognins within a 
polypeptide or a multi-subunit complex (Fig. 3A). For example, 
if a protein is properly folded or assembled into a cognate 
complex, the Ac/N-degron may be protected from the attack 
by the Ac/N-end rule pathway. Otherwise, the Ac/N-degrons 
will remain exposed, leading to their elimination by the Ac/N-
end rule pathway (Hwang et al., 2010a; Mogk and Bukau, 
2010). The conditionality of built-in Ac/N-degrons plays a piv-
otal role in the control of protein quality and the adjustment  
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of subunit stoichiometries of protein complexes (Fig. 3A). For 
example, Nt-acetylated Cog1, a subunit of the conserved oli-
gomeric Golgi (COG) complex is targeted for degradation by 
another Ac/N-recognin, Not4 E3 ligase, rather than Doa10. 
Interestingly, the short-lived Cog1 becomes longer-lived upon 
co-overexpression of the binding partner proteins Cog2, Cog3, 
and Cog4 by shielding its Ac/N-degron within the COG complex 
(Shemorry et al., 2013). The crystal structure of the Hcn1 and 
Cut9 subunits of Schizosaccharomyces pombe APC/C E3 lig-
ase suggests that Hcn1 escapes from the Ac/N-end rule path-
way by placing its acetylated Nt-Met in the cavity of Cut9 
(Zhang et al., 2010). Indeed, unmasked Hcn1 is degraded via 
its Ac/N-degron when it is heterologously expressed in S. cere-
visiae. Similar to the stoichiometry-mediated degradation con-
trol of the COG complex, co-expression of Cut9 represses the 
degradation of Hcn1 by shielding its Ac/N-degron (Shemorry et 
al., 2013). Additionally, Nt-acetylated Ser of the H4 peptide or 
Nt-acetylated Met of Dcn1 is specifically enclosed within the 
cavity of the double PHD1/2 finger DPF3b transcriptional pro-
tein or Ubc12 E3 enzyme, respectively (Scott et al., 2011; Zeng 
et al., 2010). It remains to be determined whether DPF3b and 
Ubc12 shield the Ac/N-degrons of H4 and Dcn1. The condition-
ality of the Ac/N-degron is further demonstrated in human wild-
type Rgs2, a regulator of G-protein signaling. Rgs2 bearing an 
Ac/N-degron is strongly stabilized by the co-overexpression of 
one of its binding partners, the Gq protein (Park et al., 2015). 
The conditional nature of Ac/N-degrons provides a new par-
adigm for how protein levels are sensed and balanced with 
respect to their interacting proteins. The conditionality of Ac/N-
degrons also holds true for other degrons, thus providing new 
insight into the regulation of protein quality and stoichiometric 
levels of individual proteins. For example, the steady-state lev-
els of the decapping enzyme Dcp2 are modulated by competi-
tion between its degradation and assembly into decapping 
complexes, despite the apparent internal degrons of Dcp2 
(Erickson et al., 2015). As another example, S. cerevisiae fatty 
acid synthase (FAS) complex subunits become short-lived in 
the absence of respective ligands. Interestingly, unassembled 
Fas2 is eliminated by the Ubr1-mediated degradation pathway, 
possibly via its internal degron(s), similar to subunit stoichio-
metric control by the Ac/N-end rule pathway (Scazzari et al., 
2015). In addition, frequent aneuploidy in cancer cells and tri-
somy 21 in Down syndrome may perturb input subunit stoichi-
ometries of protein complexes due to altered specific gene 
Fig. 3. Functions of the Ac/N-end rule pathway. (A) Control of protein quality and subunit stoichiometry. The Ac/N-end rule pathway targets
misfolded proteins or unassembled subunit(s) of complex proteins with Ac/N-degrons. (B) Regulation of blood pressure via G-protein signaling.
The Ac/N-end rule pathway degrades Nt-acetylated wild-type MQ-Rgs2. In contrast, the hypertension-related ML-Rgs2 with a Met-Ф degron is
targeted by either the Ac/N-end rule pathway or the Arg/N-end rule pathway according to its Nt-acetylation status. Dual targeting of ML-Rgs2
by two branches of the N-end rule pathways dramatically decreases Rgs2 levels, and thereby increases blood pressure via augmented G-
protein signaling and subsequent vasoconstriction. (C) Dysregulation of Nt-acetylation most likely affects protein stability, thus causing many
cancers. (D) Control of pathogen immunity in plants. Plants contain two SNC1 (suppressors of nod-like protein receptor 1) variants with Met-
Met-Asp (MMD) or Met-Asp (MD) N-termini owing to alternative translation. NatA Nt-acetylates MMD-SNC1 for degradation, whereas NatB Nt-
acetylates MD-SNC1 for stabilization. Consequently, the steady-state levels of SNC1 are directly involved in plant immunity. 
A                              B 
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dosages and a subsequent increase in unassembled or mis-
folded proteins (Hwang et al., 2010b). Accordingly, intracellular 
proteolytic systems are likely to regulate the subunit stoichi-
ometry of complexes by targeting aberrant or unassembled 
proteins for the maintenance of protein quality and homeostasis. 
 
THE AC/N-END RULE PATHWAY IN MAMMALS 
 
The Arg/N-end rule pathway is conserved across eukaryotic 
species, from fungi to mammals and plants, and has recently 
been identified in S. cerevisiae (Hwang et al., 2010b). We 
demonstrated the existence of the Ac/N-end rule pathway in 
mammals and identified wild-type MQ-Rgs2 (with Nt-Met-Gln), 
a regulator of G-protein signaling, as the first physiological sub-
strate of the mammalian Ac/N-end rule pathway (Park et al., 
2015) (Fig. 3B). Additionally, two hypertension-associated 2nd-
position missense human mutants, ML-Rgs2 (with Nt-Met-Leu) 
and MR-Rgs2 (with Nt-Met-Arg), are physiological substrates of 
the human Ac/N-end rule pathway (Bodenstein et al., 2007; 
Park et al., 2015). Both ML-Rgs2 and MR-Rgs2 are significantly 
shorter-lived than MQ-Rgs2, partially explaining the association 
between these mutants and hypertension in humans; reduced 
Rgs2 levels upregulate vasoconstrictors and have a weaker 
inactivation effect on Gq proteins, leading to high blood pres-
sure (Aksnes et al., 2015a; Bodenstein et al., 2007; Park et al., 
2015) (Fig. 3B). The ER membrane-embedded human Teb4 
(March6) E3 ligase, an ortholog of yeast Doa10, (Hassink et al., 
2005) was identified as the first mammalian Ac/N-recognin. 
Teb4 targets wild-type MQ-Rgs2 and hypertensive ML-Rgs2 
and MR-Rgs2 by directly recognizing their N-terminal acetyl 
groups (Park et al., 2015). While human MQ-Rgs2 and its mu-
tant MR-Rgs2 are targeted for degradation solely by the Ac/N-
end rule pathway, the other hypertension-associated (and the 
shortest-lived) ML-Rgs2 mutant is targeted by both the Ac/N-
end rule pathway (as Nt-acetylated ML-Rgs2) and the Arg/N-
end rule pathway (as Nt-unacetylated ML-Rgs2), consistent 
with the dual targeting mechanism of Met-Ф-proteins by two 
branches of the N-end rule pathways in yeast (see below). 
Consequently, the dual degradation of the hypertensive ML-
Rgs2 strongly decreases ML-Rgs2 levels, leading to high blood 
pressure by promoting Gq-protein signaling (Aksnes et al., 
2015a; Park et al., 2015) (Fig. 3B). 
Out of ~30 RGS family proteins in humans, Nt-Cys of Rgs4, 
Rgs5, and Rgs16 are subject to oxidation, Nt-arginylation, and 
subsequent degradation by the Arg/N-end rule pathway (Gibbs, 
2015; Hu et al., 2005; Lee et al., 2005; 2015). The identification 
of Rgs2 as an Ac/N-end rule substrate suggests that other 
RGS proteins, including Rgs1, Rgs6, and Rgs7, may also be 
substrates of either the Ac/N-end rule or Arg/N-end rule path-
ways depending on their Nt-sequence contexts and Nt-
acetylation states (Park et al., 2015).  
Similar to Rgs2 variants in hypertension patients, 2nd-position 
mutations are observed in many proteins, particularly in cancer 
cell exomes (Kandoth et al., 2013). Some cancer-related pro-
teins may become longer- or shorter-lived as a result of 2nd-
position mutations, which cause their targeting to either the 
Arg/N-end rule pathway or the Ac/N-end rule pathway (Table 1) 
(Fig. 3C). For example, the tumor suppressor Dab2 (Disabled 
homolog 2), 80-90% of which is lost in ovarian and breast can-
cer cells (Bagadi et al., 2007), and ENSA (α-endosulfine), of 
which overexpression suppresses hepatic tumor growth (Chen 
et al., 2013), are expected to be short-lived due to their 2nd-
position mutations in cancer cells. In contrast, Reg3A (regener-
ating islet-derived protein 3α), which accelerates pancreatic 
cancer cell growth (Liu et al., 2013), may be long-lived due to its 
2nd-position mutation. Accordingly, it is unclear whether particu-
lar 2nd-position mutations contribute to the development of ex-
tant malignant phenotypes by faster or delayed degradation of 
specific proteins (Table 1). 
A handful of cellular proteins are shown to be putative sub-
strates of the Ac/N-end rule pathway. For example, a short-lived 
endogenous p21Cip1, a CDK inhibitor in mammalian cells, is 
acetylated at its Nt-Ser, indicating that the resulting Nt-acetyl 
Ser may control the half-life of p21Cip1 (Lu and Hunter, 2010). In 
addition, C. elegans RHY-1, an ER acyltransferase-like protein, 
appears to promote the degradation of CYSL-1, a putative 
sulfhydrylase/cysteine synthase, potentially by increasing the 
Nt-acetylation of CYSL-1 (Ma et al., 2012). Furthermore, Nt-Ala 
of NaV1.5, α subunit of the cardiac voltage-gated sodium 
channel, is acetylated at the end of heart failure. The resulting 
Table 1. Cancer-related proteins with mutations at position 2 
Cancer-related proteins Original  sequence Mutations at position 2 Carcinoma 
FARSB (Phe-tRNA ligase β subunit) MPTVSV... MLTVSV... Head/neck squamous cell 
POLR2C (RNA polymerase II subunit) MPYANQ... MLYANQ.... Bladder urothelial  
eIF1AX (eukaryotic translation initiation factor 1A) MPKNKG... MSKNKG... Uterine corpus Endometrial 
Dab2 (disabled homolog 2) MSNEVE... MFNEVE... Breast invasive  
ENSA (alpha-endosulfine) MSQKQE... MYQKQE... Breast invasive  
HIST2H2AB (histone H2A type 2-B) MSGRGK... MLGRGK... Head/neck squamous cell 
Rgs2 (regulator of G-protein signaling 2) MQSAMF... MLSAMF... Breast invasive  
Cdk19 (cyclin-dependent kinase 19) MDYDFK... MYYDFK… Kidney renal clear cell 
Reg3A (regenerating islet-derived protein 3-α) MLPPMA... MPPPMA… Lung adeno 
eIF5 (eukaryotic translation initiation factor 5) MSVNVN... MPVNVN... Lung squamous cell 
* Similar to Rgs2 variants in hypertension patients, many cancer cell exomes encode cellular proteins with mutations at position 2 (Kandoth et 
al., 2013), which are likely to make cancer-related proteins shorter-lived or longer-lived by affecting two branches of the N-end rule pathways. 
2nd-position mutations listed above have mutation assessor scores above 2.0, indicating significant impacts on protein function. All information 
about cancer-related mutations was acquired and analyzed from datasets of The Cancer Genome Atlas (https://tcga-data.nci.nih.gov/tcga).  
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acetylated Nt-Ala of NaV1.5 is predicted to have an Ac/N-
degron, because its steady-state level is significantly lower in 
typical heart failure than in normal conditions (Beltran-Alvarez 
et al., 2014). However, additional studies are needed to prove 
that the Ac/N-end rule pathway mediates the degradation of 
p21Cip1, CYSL-1, and NaV1.5. 
The Ac/N-end rule pathway may alleviate ER stresses be-
cause Nt-acetylation prevents cellular protein targeting to the 
ER, leading to the elimination of retained Nt-acetylated proteins 
in the cytosol (Forte et al., 2011). Additionally, Teb4 may medi-
ate the degradation of some previously identified substrates, 
such as the thyroid hormone-activating type 2 iodothyronine 
deiodinase (D2) (Zavacki et al., 2009), the cholesterol biosyn-
thetic enzyme squalene monooxygenase (SM) (Foresti et al., 
2013; Zelcer et al., 2014), and the salt export pump BSEP 
(Wang et al., 2008), at least in part via their acetylated Nt-
residues before or after the targeting to the ER under some 
stress conditions. 
 
THE AC/N-END RULE PATHWAY IN PLANTS 
 
Nt-acetylation is also an abundant modification in plant cells, 
which contain a unique chloroplast-localized Nt-acetylase, 
AtNaa70, as well as 6 Nt-acetylases, NatA-F (Dinh et al., 2015). 
Loss of the Nt-acetylases NatA, NatB, or NatC in plants results in 
lethal or pleiotropic deleterious phenotypes (Gibbs, 2015). De-
spite the presence of SUD2 (suppressor of dry2 defects 1) E3 
ligase (Doblas et al., 2013), a sequelog of yeast Doa10 and hu-
man TEB4, the Ac/N-end rule pathway has not yet been estab-
lished in plants. Interestingly, the plant immune receptor SNC1 
(suppressor of nod-like protein receptor 1, constitutive 1) has an 
Ac/N-degron. The SNC1 contains two distinct Nt-variants starting 
with Met-Met-Asp and Met-Asp Nt-sequences, likely owing to 
alternative translation initiation; they are differentially regulated by 
NatA and NatB Nt-acetylases, respectively (Xu et al., 2015) (Fig. 
3D). More interestingly, NatA acetylates the Met-Met-Asp N-
terminus of SNC1 and triggers its degradation by creating an 
Ac/N-degron. In contrast, NatB antagonistically stabilizes SNC1 
by acetylating the Met-Asp N-terminus. These results uncover the 
first Ac/N-degron in plants and show the dual roles of Nt-
acetylation as a destabilizer or a stabilizer for newly synthesized 
proteins to reach appropriate amounts in a timely manner within a 
cell (Gibbs, 2015; Xu et al., 2015) (Fig. 3D). 
Many plastid precursor proteins are Nt-acetylated and accu-
mulate outside of plastids in the absence of Toc159, a main 
receptor for photosynthetic proteins. Consequently, Nt-
acetylated plastid precursors are most likely to be eliminated by 
the Ac/N-end rule pathway to avoid the accumulation of unfold-
ed proteins in the cytosol (Grimmer et al., 2014). Furthermore, 
populations of Nt-acetylated proteins are likely to be modulated 
in response to external stress in plants. For example, drought 
and abscisic acid-associated stresses drastically reduce Nt-
acetylated proteins through the depletion of NAA10 mRNA and 
a subsequent decrease in the Naa10 expression levels, leading 
to impaired growth and development (Linster et al., 2015). It is 
not clear whether the dramatic changes in Naa10 levels influ-
ence the degradation patterns of the global proteome by the 
Ac/N-end rule pathway. 
 
REGULATION OF THE AC/N-END RULE PATHWAY BY  
NT-ACETYLASES AND ACETYL-COA 
 
Despite the abundance and irreversibility of Nt-acetylation, the 
transcription levels of Nt-acetylase subunits change significantly 
during development or under stress conditions (Graveley et al., 
2011; Linster et al., 2015; Silva and Martinho, 2015). In addition, 
specific Nt-acetylases are modified by phosphorylation or 
acetylation for different cellular responses (Malen et al., 2009; 
Seo et al., 2010). Therefore, altered amounts or activities of 
specific Nt-acetylases are likely to affect protein expression 
patterns during development or stress conditions by changing 
the production of Ac/N-degrons. Intracellular levels of a key 
metabolic intermediate, acetyl-CoA, also change according to 
the metabolic states of cells, thus affecting gene expression, 
cell proliferation, cancer metabolism, autophagy, etc. 
(Pietrocola et al., 2015). Because acetyl-CoA acts as a co-
substrate for the reaction, its levels are also likely to affect the 
Nt-acetylation of cellular proteins. For example, reduced acetyl-
CoA levels decrease the acetylation of apoptosis effectors, thus 
linking metabolic conditions with cell death (Yi et al., 2011). The 
prevalence of Ac/N-degrons in a vast majority of proteins also 
suggests that changing acetyl-CoA levels may have effects on 
the global proteome by modulating the activities of Nt-
acetylases and Ac/N-end rule components. 
 
N-FORMYL DEGRON AND ITS RELEVANT N-END  
RULE PATHWAY IN BACTERIA 
 
The discovery of Ac/N-degrons led to the hypothesis that the 
transient Nt-formyl Met (fMet) of nascent proteins acts as an 
fMet-based N-degron owing to the similarity between acetyl and 
formyl groups on Nt-Met and their identical localization at N-
termini (Hwang et al., 2010b). The fMet residue occurs in nas-
cent proteins of bacteria and eukaryotic organelles, such as 
mitochondria and chloroplasts. The inhibition or loss of deform-
ylase activity decreases the levels of chloroplast D2 in Chla-
mydomonas reinhardtii (Giglione et al., 2003) as well as D2-
derived reporters and many high-molecular-weight proteins in E. 
coli by accelerating their degradation via the retained formyl 
group (Piatkov et al., 2015). The effects are also abrogated by 
mutations that prevent formylation. These and related findings 
strongly suggest that fMet acts as a new kind of N-degron by a 
bacterial fMet/N-end rule pathway (Piatkov et al., 2015). The 
ATP-dependent protease FtsH may be a fMet/N-recognin that 
mediates the proteolysis of the E. coli membrane protein YfgM 
by targeting its fMet (Dohmen, 2015; Piatkov et al., 2015). The 
fMet/N-end rule pathway is also thought to be involved in pro-
tein quality control by the preferential and largely cotranslational 
degradation of Nt-formylated misfolded or unassembled pro-
teins (Dohmen, 2015; Piatkov et al., 2015). 
 
CONCLUSION 
 
Most cellular proteins are Nt-acetylated, but the universal func-
tions of this modification are largely unknown. The discovery of 
Ac/N-degrons and the Ac/N-end rule pathway represents a 
remarkable breakthrough in our understanding of the cellular 
functions of Nt-acetylation. Recent studies of the Ac/N-end rule 
pathway have unraveled the complementary crosstalk between 
two branches of the N-end rule pathway, fMet/N-degrons in 
bacteria, and a wide range of cellular roles, including the control 
of protein quality and subunit stoichiometry, the regulation of 
blood pressure via G-protein signaling, and plant stress and 
immune responses. Nonetheless, the discovery of Ac/N-
degrons and the Ac/N-end rule pathway is still the beginning of 
an entirely new and broad research field. Because Ac/N-
degrons are present in nearly all proteins and can be condition-
ally modulated, a detailed understanding of the Ac/N-end rule 
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pathway will set the stage for new therapeutic approaches 
based on inhibitors or activators of MetAPs, specific Nt-
acetylases, and other components of the Ac/N-end rule path-
way, including Ac/N-recognins (Hwang et al., 2010a; Lee et al., 
2015; Park et al., 2015). 
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